Soleil Raises Price Target on Hospira (HSP) to $53
Tweet Send to a Friend
Soleil Securities Group raises its price target on Hospira (NYSE: HSP) from $47.50 to $53 and maintains a Buy rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


